St Jude Medical Inc  

(Public, NYSE:STJ)   Watch this stock  
0.0000
- Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap     -
P/E 0.00
Div/yield 0.31/∞
EPS 2.28
Shares 285.72M
Beta     -
Inst. own 84%
Jan 25, 2017
Q4 2016 St. Jude Medical Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Oct 26, 2016
St. Jude Medical Inc Annual Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q4 (Oct '16) 2016
Net profit margin 14.14% 15.63%
Operating margin 19.08% 18.59%
EBITD margin - 28.37%
Return on average assets 6.75% 7.45%
Return on average equity 19.40% 21.36%
Employees 18,000 -
CDP Score - -

Address

1 Saint Jude Medical Dr
SAINT PAUL, MN 55117-1789
United States - Map
+1-651-7562000 (Phone)
+1-651-7563301 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

St. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company's product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products.